Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Suanna Steeby Bruinooge"'
Autor:
Abdul-Rahman Jazieh, Adda Bounedjar, Hikmat Abdel-Razeq, Elif Berna Koksoy, Jawaher Ansari, Arafat H. Tfayli, Emad M. Tashkandi, Wasil A. Jastaniah, Mohamed Osama Alorabi, Amira D. Darwish, Ahmed Magdy Rabea, Ashwaq Al Olayan, Fahad Ibnshamsah, Hassan Errihani, Mohammad Omar AlKaiyat, Fazal Hussain, Khaled Alkattan, Suanna Steeby Bruinooge, Elizabeth Garrett-Mayer, Hani Tamim
Publikováno v:
Journal of Immunotherapy and Precision Oncology, Vol 7, Iss 2, Pp 82-88 (2024)
Introduction: Despite extensive studies of the impact of COVID-19 on patients with cancer, there is a dearth of information from the Middle East and North Africa (MENA) region. Our study aimed to report pertinent MENA COVID-19 and Cancer Registry (MC
Externí odkaz:
https://doaj.org/article/fc722e7c16a249d5a2d715d86049a499
Autor:
Randall A. Oyer, Patricia Hurley, Leigh Boehmer, Suanna Steeby Bruinooge, Kathryn Levit, Nadine Barrett, Al Benson, Lea Ann Bernick, Leslie Byatt, Marjory Charlot, Jennie Crews, Kyle DeLeon, Lola Fashoyin-Aje, Elizabeth Garrett-Mayer, Julie R. Gralow, Sybil Green, Carmen E. Guerra, Leila Hamroun, Claudia M. Hardy, Bridgette Hempstead, Sanford Jeames, Mel Mann, Khalid Matin, Worta McCaskill-Stevens, Janette Merrill, Grzegorz S. Nowakowski, Manali I. Patel, Alice Pressman, Amelie G. Ramirez, Juanita Segura, Barbara Segarra-Vasquez, Jen Hanley Williams, James E. Williams, Karen M. Winkfield, Eddy S. Yang, Victoria Zwicker, Lori J. Pierce
Publikováno v:
Journal of Clinical Oncology. 40:2163-2171
A concerted commitment across research stakeholders is necessary to increase equity, diversity, and inclusion (EDI) and address barriers to cancer clinical trial recruitment and participation. Racial and ethnic diversity among trial participants is k
Autor:
Nadine Barrett, Leigh Boehmer, Janelle Schrag, Al Bowen Benson, Sybil Green, Leila Hamroun, Alexandra Howson, Khalid Matin, Randall A. Oyer, Lori J. Pierce, Sanford Earl Jeames, Karen Marie Winkfield, Eddy Shih-Hsin Yang, Victoria Zwicker, Suanna Steeby Bruinooge, Patricia A. Hurley, Jen Hanley Hanley Williams, Carmen Guerra
Publikováno v:
Journal of Clinical Oncology. 40:e18599-e18599
e18599 Background: Low participation of Black, Hispanic, Latinx and other underrepresented racial/ethnic groups in clinical research remains a problem across the U.S. Recent studies have highlighted that stereotypes, assumptions, and bias play a role
Autor:
Alice R. Pressman, Patricia A. Hurley, Melinda Kaltenbaugh, Suanna Steeby Bruinooge, Elizabeth Garrett-Mayer, Leigh Boehmer, Lea Ann Bernick, Leslie Byatt, Marjory Charlot, Jennie Robertson Crews, Lola A. Fashoyin-Aje, Worta J. McCaskill-Stevens, Grzegorz S. Nowakowski, Randall A. Oyer, Manali I. Patel, Lori J. Pierce, Amelie G. Ramirez, Jen Hanley Hanley Williams, Victoria Zwicker, Carmen Guerra
Publikováno v:
Journal of Clinical Oncology. 40:6530-6530
6530 Background: Only a small fraction of patients with cancer participate in treatment trials. Patients identifying as members of racial and ethnic minority groups are consistently underrepresented in these trials. A recent systematic review reporte
Autor:
Rachel Jimenez, Caroline Schenkel, Laura Levit, Bonnie Hu, R. Donald Harvey, Vicki A. Morrison, Teri Pollastro, David Michael Waterhouse, Colin D. Weekes, Grant Richard Williams, Suanna Steeby Bruinooge, Elizabeth Garrett-Mayer, Jeffrey M. Peppercorn
Publikováno v:
Journal of Clinical Oncology. 40:1531-1531
1531 Background: The goal of treatment for patients with metastatic cancer (MC) is to prolong and maintain quality of life. Patients and oncologists have questioned the current paradigm of initial dose selection for systemic therapy and want addition
Autor:
Abdul-Rahman Jazieh, Hikmat Abdel-Razeq, Hakan Akbulut, Adda Bounedjar, Arafat H. Tfayli, Emad M Tashkandi, Wasil A Jastaniah, Jawaher Ansari, Mohamed Osama Alorabi, Amira D Darwish, Ahmed Magdy Rabea, Ashwaq Al Olayan, Fahad Ibnshamsah, Hassan Errihani, Mohammad Alkaiyat, Khaled Alkattan, Fazal Hussain, Suanna Steeby Bruinooge, Elizabeth Garrett-Mayer, Hani Tamim
Publikováno v:
Journal of Clinical Oncology. 40:e18797-e18797
e18797 Background: Patients with cancer are vulnerable population that suffered during the COVID-19 pandemic from SARS-CoV-2 infection and from the pandemic’s impact on healthcare systems. We are presenting the findings of MENA Registry for COVID-1
Autor:
Suanna Steeby Bruinooge, Dax Kurbegov, Melinda Kaltenbaugh, Jen Hanley Hanley Williams, Julie R. Gralow, Elizabeth Garrett-Mayer
Publikováno v:
Journal of Clinical Oncology. 40:e18807-e18807
e18807 Background: The ASCO Registry was created to analyze the impact of COVID-19 (COVID) on treatment (Tx) and outcomes of patients (pts) with cancer. Vaccination questions were added in 2021, enabling examination of breakthrough cases i.e., SAR
Autor:
Kathryn Finch Mileham, Elizabeth Garrett-Mayer, Melinda Kaltenbaugh, Margaret Kelsey Kirkwood, Caroline Schenkel, Suanna Steeby Bruinooge, Raymond U. Osarogiagbon, Shadia Ibrahim Jalal, Amy Moore, Upal Kunal Basu Roy, Janet Freeman-Daily, Shamsuddin Virani, Edward B. Garon, Gerard A. Silvestri, Lauren Rosenthal, Robert A. Smith, Bruce E. Johnson
Publikováno v:
Journal of Clinical Oncology. 40:9127-9127
9127 Background: Guidelines have evolved from 2011-2019; there are now 23 approved therapies targeting various predictive biomarkers in mNSCLC. 2021 NCCN Guidelines advocate for a minimum of ALK, EGFR, BRAF, METex14, NTRK1/2/3, RET, KRAS, and ROS1 te